2014 - 2014
Publish listed in Taiwan OTC stock market in October (code: 4192).
- Received “The 10th National Innovation Award”.
SB05 CTA (IND) received FAMHP approval to conduct phase 3 clinical trial in Belgium.
Publish listed in Taiwan OTC stock market in October (code: 4192).
SB05 CTA (IND) received FAMHP approval to conduct phase 3 clinical trial in Belgium.